Nashville, Tenn., Sept. 3 -- The State of Tennessee Department Of Revenue (34717-01017) for Unclaimed Vehicle Portal. Description: The State is looking for a single, experienced vendor to implement ... Read More
Jakarta, March 31 -- Indonesian President Prabowo Subianto witnessed the announcement of 10 memoranda of understanding (MoUs) and agreements between Indonesian and Japanese business players worth US$2... Read More
Imphal, March 31 -- In a series of operations conducted in Manipur, security forces have arrested six militants. Published by HT Digital Content Services with permission from United News of India.... Read More
Bangladesh, March 31 -- Bollywood superstar Shah Rukh Khan's presence at a family function of an Indian BJP leader has sparked a new social media frenzy. The actor, who has always maintained a distan... Read More
Bangladesh, March 31 -- Lahore Qalandars lost to Karachi Kings by 4 wickets in the second match of the day in the Pakistan Super League (PSL) on Sunday. However, Mustafizur Rahman once again shone wit... Read More
భారతదేశం, మార్చి 31 -- బాలీవుడ్ వెర్సటైల్ హీరోయిన్ భూమి పెడ్నేకర్ తన కెరీర్ ఆరంభం నుంచి బాడీ ట్రాన్స్ఫార్మేషన్ విషయంలో వార్తల్లో నిలుస్తూనే ఉన్నారు. తొలి సినిమా 'దమ్ లగా కే హయిషా' కోసం భారీగా బరువు ప... Read More
Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More
Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More
Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More